0 Commentaires
0 Parts
100 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
How are new therapies reshaping the urothelial cancer drugs market?Competitive Analysis of Executive Summary Urothelial Cancer Drugs Market Size and Share CAGR Value The global Urothelial Cancer Drugs market size was valued at USD 1.44 billion in 2024 and is expected to reach USD 2.80 billion by 2032, at a CAGR of 8.7% during the forecast period Keeping into consideration the customer requirement, an influential Urothelial Cancer Drugs...0 Commentaires 0 Parts 525 Vue 0 Aperçu
-
North America Anemia Drugs Market Set to Reach USD 5.9 Billion by 2032 Amid Rising CKD and Cancer CasesAccording to a new report from Intel Market Research, the North America Anemia Drugs Market was valued at USD 4,200 million in 2024 and is projected to grow from USD 4,410 million in 2025 to reach USD 5,900 million by 2032, growing at a CAGR of approximately 4.3% during the forecast period (2025–2032). This steady expansion is driven by the high and growing prevalence of chronic kidney...0 Commentaires 0 Parts 32 Vue 0 Aperçu
-
Spindle Cell Sarcoma Drugs Market – Targeted Oncology Therapies & Rare Cancer Treatment Progress"Executive Summary Spindle Cell Sarcoma Drugs Market Opportunities by Size and Share CAGR Value Data Bridge Market Research analyses that the global spindle cell sarcoma drugs market is expected which was USD 27030.00 million 2022 is expected to reach USD 43081.71 million 2030 to undergo a CAGR of 6.00% during the forecast period 2023-2030. The leading Spindle Cell Sarcoma Drugs...0 Commentaires 0 Parts 468 Vue 0 Aperçu
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Commentaires 0 Parts 323 Vue 0 Aperçu
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Commentaires 0 Parts 915 Vue 0 Aperçu
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Commentaires 0 Parts 269 Vue 0 Aperçu
-
Global Raloxifene Hydrochloride Market Growing at 5.8% CAGR Driven by Dual Benefits in Bone Health & Cancer PreventionAccording to a new report from Intel Market Research, the global Raloxifene Hydrochloride market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.75 billion by 2034, growing at a steady CAGR of 5.8% during the forecast period (2026-2034). This growth is fueled by increasing osteoporosis prevalence among aging populations, expanding applications in breast cancer prevention,...0 Commentaires 0 Parts 284 Vue 0 Aperçu
-
Sweet Potatoes Market Leaders: Growth, Share, Value, Size, and Scope"Key Drivers Impacting Executive Summary Sweet Potatoes Market Size and Share The global sweet potatoes market size was valued at USD 37.11 billion in 2024 and is expected to reach USD 59.60 billion by 2032, at a CAGR of 6.10% during the forecast period Business intelligence has been employed here to create Sweet Potatoes Market report which is...0 Commentaires 0 Parts 6KB Vue 0 Aperçu
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Commentaires 0 Parts 283 Vue 0 Aperçu
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Commentaires 0 Parts 245 Vue 0 Aperçu
-
What advancements are shaping the Waldenstrom’s macroglobulinemia treatment market?Key Drivers Impacting Executive Summary Waldenstrom’s Macroglobulinemia (WM) Treatment Market Size and Share CAGR Value The Global Waldenstrom’s Macroglobulinemia (WM) Treatment Market size was valued at USD 160.50 million in 2024 and is expected to reach USD 228.70 million by 2032, at a CAGR of 5.20% during the forecast period Analysis and discussion of important...0 Commentaires 0 Parts 424 Vue 0 Aperçu
-
What breakthroughs are propelling the thyroid cancer drug market forward?Executive Summary Thyroid Cancer Drug Market Value, Size, Share and Projections CAGR Value Data Bridge Market Research analyses that the global thyroid cancer drug market which was USD 712.56 million in 2022, is expected to reach USD 2,505.56 million by 2030, and is expected to undergo a CAGR of 17.2% during the forecast period 2023-2030. The world class Thyroid Cancer Drug...0 Commentaires 0 Parts 492 Vue 0 Aperçu
Plus de résultats
English
Kiswahili
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
